Physician profile
Stephen Tang
NPI 1750487401
$1,281.34
in general payments reported to CMS, 2019-2025
16 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $94.75 · 2021: $196 · 2022: $142 · 2023: $190 · 2024: $352 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451 · Travel and Lodging: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.51 |
| Travel and Lodging | $279.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $329.28 | 2021-2024 | Thermocool Sf |
| Abbott Laboratories | $170.01 | 2022-2023 | Aveir |
| Kaleo, INC. | $150.57 | 2019-2024 | Auvi-Q |
| Adlon Therapeutics L.P. | $104.08 | 2020-2021 | |
| Sanofi Pasteur INC. | $96.85 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $86.17 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $80.65 | 2021-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Takeda Pharmaceuticals U.S.A., INC. | $48.67 | 2019-2021 | |
| Glaxosmithkline, LLC. | $44.57 | 2019-2025 | Bexsero |
| Boston Scientific Corporation | $35.92 | 2025 | Watchman |
| Cranial Technologies, INC | $35.21 | 2022-2025 | Doc Band |
| Pfizer INC. | $32.70 | 2025 | |
| Vertical Pharmaceuticals, LLC | $19.48 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.59 | 2024 | |
| Ironshore Pharmaceuticals INC. | $17.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.